SRC and breast cancer: Indeed, Finn et al (2007) recently reported a highly significant relationship between breast cancer cell line subtype based on gene expression of cytokeratins and sensitivity to src kinase inhibition, suggesting that the ‘triple negative’ breast cancers were most likely to benefit from Src inhibition.